We are live on ! Find out more
APVO icon

Aptevo Therapeutics
APVO

0 hedge funds and large institutions have $12.4K invested in Aptevo Therapeutics in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

96% less capital invested

Capital invested by funds: $352K → $12.4K (-$339K)

100% less funds holding

Funds holding: 2 → 0 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
–
Holders Change
-2
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$94K
2
SM
Sabby Management
Florida
-$63.3K
3
Citadel Advisors
Citadel Advisors
Florida
-$47.4K
4
SSA
Schonfeld Strategic Advisors
New York
-$28.8K
5
Squarepoint
Squarepoint
New York
-$25.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
1
Tower Research Capital (TRC)
New York
$6.21K – – –
BlackRock
2
BlackRock
New York
$4.17K – – –
Morgan Stanley
3
Morgan Stanley
New York
$910 – – –
Qube Research & Technologies (QRT)
4
Qube Research & Technologies (QRT)
United Kingdom
$469 – – –
Osaic Holdings
5
Osaic Holdings
Arizona
$211 – – –
JP Morgan Chase
6
JP Morgan Chase
New York
$202 – – –
Wells Fargo
7
Wells Fargo
California
$169 – – –
Fifth Third Bancorp
8
Fifth Third Bancorp
Ohio
$28 – – –
PNC Financial Services Group
9
PNC Financial Services Group
Pennsylvania
$14 – – –
TC
10
Truvestments Capital
Florida
$9 – – –
Renaissance Technologies
11
Renaissance Technologies
New York
– -$94K -1 Closed
SM
12
Sabby Management
Florida
– -$63.3K -1 Closed
AF
13
Allworth Financial
California
– -$4 – –
AC
14
Armistice Capital
New York
– -$11.1K – –
BBA
15
Baader Bank Aktiengesellschaft
Germany
– -$2.03K – –
Bank of America
16
Bank of America
North Carolina
– -$1 – –
CF
17
Cantor Fitzgerald
New York
– -$10.6K – –
Citadel Advisors
18
Citadel Advisors
Florida
– -$47.4K – –
Citigroup
19
Citigroup
New York
– -$2 – –
DWA
20
Divergent Wealth Advisors
Utah
– -$1.81K – –
Franklin Resources
21
Franklin Resources
California
– -$1.99K – –
Geode Capital Management
22
Geode Capital Management
Massachusetts
– -$7.82K – –
Millennium Management
23
Millennium Management
New York
– -$18.9K – –
Northern Trust
24
Northern Trust
Illinois
– -$2.56K – –
SSA
25
Schonfeld Strategic Advisors
New York
– -$28.8K – –
1
2

APVO Hedge Fund Activity: Q1 2024 in Review

0 of the 6,944 institutional investors tracked by Wall St. Rank reported a position in Aptevo Therapeutics (APVO) for Q1 2024, worth a combined $12.4K — down 96% from $352K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of APVO and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Renaissance Technologies, exiting entirely with an estimated $94K sold.

  • 0 institutional investors held Aptevo Therapeutics (APVO) as of Q1 2024, down from 2 in Q4 2023.
  • Funds reported $12.4K of Aptevo Therapeutics stock for Q1 2024, down 96% quarter-over-quarter.
  • 0 funds opened new Aptevo Therapeutics positions in Q1 2024 and 2 closed out, a net change of -2 holders.
  • The largest Aptevo Therapeutics seller in Q1 2024 was Renaissance Technologies, an estimated $94K sold.

Based on aggregated 13F filings for Q1 2024.